Cern Corporation

Microbicidal Light for mitigation of yeast and bacterial vaginosis w/o drugs. Address unmet need for those for whom drug based care is not appropriate/desired.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Trabuco Canyon, CA, USA
  • Currency USD
  • Founded July 2019
  • Employees 1
  • Incorporation Type C-corp
  • Website http://None currently

Company Summary

Cern Corp, Inc. (Cern) SoCal based Delaware “C” formed to develop/ commercialize an effective, non-drug (drug/photosensitizer optional) therapeutic treatment for fungal and bacterial vaginosis using low-level microbicidal light administered as a small insertable device. USPTO Patents now granted both Utility and Design as well as Trademark. FDA Pre-Sub complete indicated DeNovo 510K as a Class II device with well defined development path.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free